Want to see CH:EVE full AI Analyst Report?

Evolva Holding (EVE) Price & Analysis

3 Followers

EVE Stock Chart & Stats

CHF2.24

-CHF0.13(-5.80%)

At close: Jul 27 4:00 PM EDT

CHF2.24

-CHF0.13(-5.80%)

Day’s Range― - ―

52-Week RangeCHF0.75 - CHF2.74

Previous CloseN/A

Volume1.72K

Average Volume (3M)6.26K

Market Cap

CHF17.53M

Enterprise ValueCHF6.22M

Total Cash (Recent Filing)CHF5.61M

Total Debt (Recent Filing)CHF0.00

Price to Earnings (P/E)―

Beta0.28

Next Earnings

Aug 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.09

Shares Outstanding7,230,626

10 Day Avg. Volume6,146

30 Day Avg. Volume6,263

Financial Highlights & Ratios

PEG Ratio0.05

Price to Book (P/B)0.98

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.5

Revenue Forecast (FY)CHF60.90M

Bulls Say, Bears Say

Bulls Say

Low Financial LeverageNo reported debt limits interest obligations and refinancing exposure, giving Evolva greater financial flexibility than a similarly loss-making company. However, this advantage is tempered by declining assets and equity caused by ongoing operating losses.

Reduced Cash BurnA materially lower cash outflow could extend the company’s financial runway and reduce immediate funding pressure. The benefit remains conditional because operating and free cash flow were still negative, so the business has not yet reached self-funding operations.

Biotechnology Platform HeritageExperience across fermentation and biotechnology applications provides specialized know-how and a foundation for potential commercialization in several end markets. The opportunity is limited by the absence of current revenue, so this is a capability rather than proven operating strength.

Bears Say

Zero Revenue BaseZero reported revenue indicates that Evolva currently lacks operating scale and has not demonstrated sustained customer commercialization. Without a revenue base, the company has limited evidence of product-market traction and remains highly dependent on capital, asset sales, or strategic actions.

Persistent Negative Cash FlowConsistently negative operating and free cash flow shows that the business has not funded itself through operations over multiple years. Continued cash consumption can erode financial resources and constrain investment unless commercialization or external funding improves.

Unstable Profitability And Shrinking CapitalThe reversal from 2024 profit to 2025 losses demonstrates that earnings are not yet repeatable or dependable. Declining equity and assets further indicate that operating weakness is consuming the capital base, reducing resilience and shareholder value creation.

Evolva Holding News

EvoNext in advanced talks on reverse merger with AI sports tech firm Ascend

Evolva Holding ( ($CH:EVE) ) has provided an update. EvoNext Holdings SA has confirmed it is in advanced...

6d ago

EvoNext Wins Shareholder Backing for Governance Changes to Pursue Reverse Takeover

Evolva Holding ( ($CH:EVE) ) has issued an update. Shareholders of EvoNext Holdings SA approved all board proposals...

3M ago

EvoNext posts low 2025 cash burn as it pursues reverse takeover and eyes arbitration upside

An update from Evolva Holding ( ($CH:EVE) ) is now available. EvoNext Holdings SA has released its 2025...

4M ago

EvoNext Holdings Reports 2025 Half-Year Financials and Strategic M&A Plans

Evolva Holding ( ($CH:EVE) ) just unveiled an update. EvoNext Holdings SA, formerly Evolva Holding SA, has released...

1y ago

Evolva Holding SA Rebrands to EvoNext Holdings SA

The latest announcement is out from Evolva Holding ( ($CH:EVE) ). Evolva Holding SA, a company listed on...

1y ago

Evolva Holding, Grace Breeding partner for bio-fertilizer alternative

Grace Breeding and Evolva Holding announced the formation of a partnership to support the development of a bio-fertilizer...

3y ago

EVE FAQ

What was Evolva Holding’s price range in the past 12 months?

Evolva Holding lowest stock price was CHF0.75 and its highest was CHF2.74 in the past 12 months.

What is Evolva Holding’s market cap?

Evolva Holding’s market cap is CHF17.53M.

When is Evolva Holding’s upcoming earnings report date?

Evolva Holding’s upcoming earnings report date is Aug 26, 2026 which is in 2 days.

How were Evolva Holding’s earnings last quarter?

Evolva Holding released its earnings results on Apr 29, 2026. The company reported -CHF0.04 earnings per share for the quarter, missing the consensus estimate of N/A by -CHF0.04.

Is Evolva Holding overvalued?

According to Wall Street analysts Evolva Holding’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Evolva Holding pay dividends?

Evolva Holding does not currently pay dividends.

What is Evolva Holding’s EPS estimate?

Evolva Holding’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Evolva Holding have?

Evolva Holding has 7,230,626 shares outstanding.

What happened to Evolva Holding’s price movement after its last earnings report?

Evolva Holding reported an EPS of -CHF0.04 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.04%.

Which hedge fund is a major shareholder of Evolva Holding?

Currently, no hedge funds are holding shares in CH:EVE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Evolva Holding

EvoNext Holdings SA is dedicated to the exploration, creation, and distribution of pioneering ingredients across the nutritional, health, and wellness domains. Founded in 2004, the company's inception is attributed to Alexandra Santana Sørensen, Søren V. S. Nielsen, and Neil Goldsmith. Its corporate headquarters are located in Reinach, Switzerland.